Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

QLT INC T.QLT

"QLT Inc is a biotechnology company conducts development and commercialization of ocular products that address the unmet medical needs of patients and clinicians."


TSX:QLT - Post by User

Bullboard Posts
Post by AgentCooperon Feb 06, 2002 7:00pm
1418 Views
Post# 4743388

forecast 2002

forecast 2002Should there be some concern that their forecast for 2002 is so unsure they state that earnings are going to be between 0.35 and 0.60... compared to 0.34 for this year... not much growth if they only hit 0.35... from the newsrelease2002 Guidance "The company expects Visudyne sales in the range of $435 million to $550 million (US$275 million to US$350 million) or growth over 2001 in the 25% to 55% range. Pro Forma EPS for 2002 are expected to range from $0.35 to $0.60, compared to $0.34 in 2001." Thanks Cooper
Bullboard Posts